pharmafileOctober 19, 2018
Tag: GSK , GlaxoSmithKline , Labor
The reason for the layoffs originates in the expiry of a contract manufacturing agreement by January 2019, which the company confirmed it would not be renewing.
"Due to this business change, GSK has filed a WARN (Worker Adjustment and Retraining Notification Act) notice with the Tennessee Department of Labor, to inform that we currently anticipate that 99 employees will be displaced between December 2018 and April 2019," said GSK spokeswoman Caryn Previdi.
Specifically, the cuts will come into effect from 10 December to 2 April, according to the company’s WARN notice. After the 99 roles have been axed, 160 positions will remain at the site.
"We have a loyal and committed workforce at our Memphis site and this decision is no reflection on the team or their performance," Previdi continued. "Teams at the Memphis site have demonstrated a great level of commitment to the business and we very much appreciate their dedication and hard work."
-----------------------------------------------------------------------------
Editor's Note:
To apply for becoming a contributor of En-CPhI.cn,
welcome to send your CV and sample works to us,
Email: Julia.Zhang@ubmsinoexpo.com.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: